Key terms
About BMY
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest BMY news
Yesterday
6:18am ET
Bristol Myers price target raised to $52 from $51 at Wells Fargo
Yesterday
6:10am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Accolade (ACCD), Ultragenyx Pharmaceutical (RARE) and Bristol-Myers Squibb (BMY)
Apr 12
6:00am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (BMY) and Roche Holding AG (OtherRHHVF)
Apr 12
5:25am ET
Bristol-Myers Squibb: A Buy Rating on Undervaluation and Promising Product Portfolio
Apr 08
11:33am ET
Bristol Myers: Krazati plus cetuximab showed ORR of 34%, PFS of 6.9 months
Apr 08
5:47am ET
Bristol-Myers Squibb’s Hold Rating: Balancing KarXT’s Efficacy and Safety with Financial Uncertainties
Apr 07
6:44am ET
Bristol Myers presents new data from Phase 3 EMERGENT program evaluating KarXT
Apr 07
6:34am ET
Bristol Myers presents new interim long-term efficacy data from EMERGENT-4 trial
Apr 05
9:08am ET
Bristol Myers, 2seventy Bio’s Abecma approved by U.S. FDA
Apr 03
4:03pm ET
Standard BioTools announces multi-year agreement with Bristol Myers
Apr 03
5:56am ET
Bristol Myers: European Commission expands approval of Reblozyl
Apr 03
5:16am ET
Wells Fargo Sticks to Its Hold Rating for Bristol-Myers Squibb (BMY)
Apr 01
7:39am ET
Zai Lab, Bristol Myers: Krazati confirmatory trial meets PFS primary endpoints
Mar 31
5:25am ET
Ex-Dividend Date Nearing for These 10 Stocks – Week of April 1, 2024
Mar 29
8:30am ET
Bristol Myers ends collaboration agreement with Molecular Templates
Mar 28
5:20pm ET
Bristol Myers Squibb (NYSE:BMY) Slips after Disappointing Drug Trial
Mar 28
4:15pm ET
Bristol Myers says KRYSTAL-12 trial met primary endpoint in PFS
Mar 28
4:02pm ET
Bristol Myers: Phase 3 YELLOWSTONE trial did not meet primary endpoint
Mar 25
11:46am ET
Bristol Myers Squibb call volume above normal and directionally bullish
Mar 20
4:52pm ET
Bristol Myers’ Abecma approved in the EU for multiple myeloma
Mar 20
7:05am ET
Bristol Myers says Phase 3 CheckMate -9DW trial met primary endpoint
Mar 20
7:01am ET
Bristol Myers announces the Phase 3 CheckMate -9DW trial
Mar 19
1:32pm ET
This radiopharma name seen as ‘poised for takeout’ following Fusion deal
Mar 19
12:55pm ET
Actinium Pharmaceuticals price target raised to $30 from $20 at Maxim
Mar 19
1:37am ET
Hold Rating on Bristol-Myers Squibb Amidst NSCLC Trial Uncertainties and Pending KarXT Results
Mar 18
5:52pm ET
Gerald Storch Exits, Bristol-Myers Squibb Board Shrinks
Mar 18
9:19am ET
Arcellx price target raised to $81 from $72 at Needham
Mar 18
9:07am ET
Bristol Myers completes acquisition of Karuna Therapeutics
Mar 18
8:15am ET
Perspective Therapeutics announces collaboration agreement with Bristol Myers
Mar 18
5:15am ET
Hold Rating on Bristol-Myers Squibb Amid Mixed Clinical Outcomes and Market Competition
Mar 15
6:30pm ET
Bristol Myers, 2seventy Bio: FDA’s ODAC votes in favor of Abecma
Apr 14
10:16am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY
Apr 11
9:10am ET
Building a Better Future: Bristol Myers Squibb 2023 ESG Report
Apr 08
7:00am ET
Bristol Myers Squibb Releases 2023 ESG Report Demonstrating Progress and Setting New Long-Term Goals
Apr 06
3:02pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY
Apr 02
2:30pm ET
Bristol Myers Squibb Releases 2023 Environmental, Social and Governance Report Demonstrating Progress and Setting New Long-Term Goals
Mar 29
11:26am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY
Mar 29
9:45am ET
Bristol Myers Squibb Expands Health Equity Grant Initiatives to Improve Health Outcomes
Mar 21
1:28pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY
Mar 14
8:15am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY
BMY Financials
Key terms
Ad Feedback
BMY Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
BMY Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range